GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Clinical Laserthermia Systems AB (OSTO:CLS B) » Definitions » Cash Flow from Operations

Clinical Laserthermia Systems AB (OSTO:CLS B) Cash Flow from Operations : kr-58.50 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Clinical Laserthermia Systems AB Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Mar. 2024, Clinical Laserthermia Systems AB's Cash Receipts from Operating Activities was kr2.40 Mil. Its Cash Payments was kr-22.90 Mil. Its Dividends Paid was kr0.00 Mil. Its Dividends Received was kr0.00 Mil. Its Interest Paid was kr-0.01 Mil. Its Interest Received was kr0.00 Mil. Its Taxes Refund Paid was kr-0.02 Mil. And its Cash Flow from Others was kr0.00 Mil. In all, Clinical Laserthermia Systems AB's Cash Flow from Operations for the three months ended in Mar. 2024 was kr-20.53 Mil.


Clinical Laserthermia Systems AB Cash Flow from Operations Historical Data

The historical data trend for Clinical Laserthermia Systems AB's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinical Laserthermia Systems AB Cash Flow from Operations Chart

Clinical Laserthermia Systems AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -38.72 -39.12 -55.41 -66.18 -81.53

Clinical Laserthermia Systems AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.15 -14.53 -15.16 -22.81 -20.53

Clinical Laserthermia Systems AB Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Clinical Laserthermia Systems AB's Cash Flow from Operations for the fiscal year that ended in Dec. 2022 is calculated as:

Clinical Laserthermia Systems AB's Cash Flow from Operations for the quarter that ended in Mar. 2024 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-58.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinical Laserthermia Systems AB  (OSTO:CLS B) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Clinical Laserthermia Systems AB's cash receipts from operating activities for the three months ended in Mar. 2024 was kr2.40 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Clinical Laserthermia Systems AB's cash payments for the three months ended in Mar. 2024 was kr-22.90 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Clinical Laserthermia Systems AB's cash payments for the three months ended in Mar. 2024 was kr0.00 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Clinical Laserthermia Systems AB's cash payments for the three months ended in Mar. 2024 was kr0.00 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Clinical Laserthermia Systems AB's cash payments for the three months ended in Mar. 2024 was kr-0.01 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Clinical Laserthermia Systems AB's cash payments for the three months ended in Mar. 2024 was kr0.00 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Clinical Laserthermia Systems AB's cash payments for the three months ended in Mar. 2024 was kr-0.02 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Clinical Laserthermia Systems AB's cash flow from others for the three months ended in Mar. 2024 was kr0.00 Mil.


Clinical Laserthermia Systems AB Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Clinical Laserthermia Systems AB's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinical Laserthermia Systems AB (OSTO:CLS B) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.

Clinical Laserthermia Systems AB (OSTO:CLS B) Headlines

No Headlines